Whole-cell extracts were prepared and subjected to immunoblotting as previously described (23 (link)). Immunoblotting was performed using antibodies against pS1981 ATM (AF1655) from R&D Systems; ATM (A300-299A), pS824-KAP1 (A300-767A), KAP1 (A300-274A), pS966-SMC1 (A300-050A), SMC1 (A300-055A), pS4/S8-RPA2 (A300-245A), and RECQL1 (A300-450A) from Bethyl Laboratories; pS345-CHK1 (2341) from Cell Signaling Technology; CHK1 (sc-8408) and PARP1 (sc-8007) from Santa Cruz Biotechnology; H2A (07-146), γ-H2AX (05-636), RPA2 (NA18), and HA (H9658) from Merck; pS343-NBS1 (47272) from Abcam; and Nbs1 (GTX70224) from GeneTex. Co-immunoprecipitation was carried out as previously described (23 (link)), with the exception that EDTA was excluded, and 250 units/mL benzonase (Merck) and 1.5 mM MgCl2 were added to the lysis buffer. Anti-RECQL1 antibody (5 μg, A300-450A) or a nonspecific IgG (Dako) coupled with protein A agarose beads (GE Healthcare) were used to isolate protein complexes from 5 mg whole-cell extract.
Free full text: Click here